share_log

Immunovant: Q1 Earnings Insights

Immunovant: Q1 Earnings Insights

免疫藥物:第一季度收益洞察
Benzinga Real-time News ·  2022/08/05 17:50

Immunovant (NASDAQ:IMVT) reported its Q1 earnings results on Friday, August 5, 2022 at 07:00 AM.

免疫抗體納斯達克(股票代碼:IMVT)於2022年8月5日(星期五)上午07:00公佈了第一季度收益業績。

Here's what investors need to know about the announcement.

以下是投資者需要知道的關於這一聲明的信息。

Earnings

收益

Immunovant beat estimated earnings by 12.5%, reporting an EPS of $-0.35 versus an estimate of $-0.4.

免疫系統比預期收益高出12.5%,每股收益為-0.35美元,而預期為-0.4美元。

Revenue was down $0 from the same period last year.

營收比去年同期下降了0美元。

Past Earnings Performance

過去的盈利表現

Last quarter the company missed on EPS by $0.03 which was followed by a 4.85% drop in the share price the next day.

上個季度,該公司每股收益比預期低0.03美元,第二天股價下跌了4.85%。

To track all earnings releases for Immunovant visit their earnings calendar here.

要跟蹤免疫系統的所有收益情況,請訪問他們的收益日曆。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自動內容引擎生成,並由編輯審閲。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論